Uncoupling bone turnover with strontium ranelate, a promising agent for the treatment of postmenopausal osteoporosis

被引：0
|
作者：
Christiansen, C [1 ]
Tankó, LB [1 ]
机构：
[1] Ctr Clin & Basic Res, Ballerup, Denmark
来源：
OSTEOPOROSIS INTERNATIONAL | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [21] Assessment of OPG, RANKL, bone turnover markers serum levels, and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis
    Stuss, Michal
    Sewerynek, Ewa
    Krol, Iwona
    Stepien-Klos, Wioletta
    Jedrzejczyk, Slawomir
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (02) : 174 - 184
  • [22] Strontium ranelate - a promising therapeutic principle in osteoporosis
    Boivin, Georges
    Doublier, Audrey
    Farlay, Delphine
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2012, 26 (2-3) : 153 - 156
  • [23] Strontium ranelate in the treatment of osteoporosis
    Hough, Stephen
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2006, 11 (01) : 7 - 8
  • [24] STRONTIUM RANELATE IN THE TREATMENT OF OSTEOPOROSIS
    Maria Galich, Ana
    ACTUALIZACIONES EN OSTEOLOGIA, 2011, 7 (01) : 19 - 34
  • [25] Strontium Ranelate in the Treatment of Osteoporosis
    Kurth, A.
    ORTHOPADE, 2014, 43 (02): : 181 - 181
  • [26] Strontium ranelate: New efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women
    Meunier, PJ
    Lorenc, RS
    Smith, IG
    Roces-Varela, A
    Passariello, R
    Bonidan, O
    Kruse, HP
    Raeman, F
    Prince, R
    De Chatel, R
    Charles, P
    Fechtenbaum, J
    Roux, C
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S34 - S34
  • [27] Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy
    Blake, Glen M.
    Fogelman, Ignac
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 367 - 375
  • [28] The mode of action of strontium ranelate - A novel treatment option for postmenopausal osteoporosis
    Dimai, H. P.
    BONE, 2006, 39 (05) : S19 - S19
  • [29] Possibility of bone metabolism modulator (strontium ranelate) usage for the treatment of women with postmenopausal osteoporosis and arterial hypertension
    Hozjainova, N. J.
    Tsareva, V. M.
    Brook, T. V.
    Bezaltynnyh, M. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (02) : 18 - 21
  • [30] The effects of strontium ranelate on bone remodeling and bone safety assessed by histomorphornetry in patients with postmenopausal osteoporosis
    Arlot, ME
    Delmas, P
    Burt-Pichat, B
    Roux, JP
    Portero, N
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S22 - S23
12345